Recursion Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 298.58M610.35M701.29M653.70M1448.60M
Current Assets
Cash & Equivalents 262.13M285.12M549.91M391.56M594.35M
Short-term Investments 2.00M231.45M1.28M3.23M3.04M
Cash & Current Investments 264.13M516.56M551.19M394.80M597.39M
Receivables - Net 0.16M0.03M
Receivables - Other 9.06M2.75M3.09M49.17M
Receivables 0.16M9.09M
Prepaid Assets 2.15M7.51M15.87M40.25M38.11M
Current Assets 266.44M534.72M569.81M438.14M714.27M
Non-Current Assets
Property, Plant & Equipment (Net) 25.97M64.72M88.19M86.51M141.06M
Goodwill 0.80M0.80M0.80M52.06M148.87M
Intangibles 1.69M1.39M1.31M36.44M335.86M
Goodwill & Intangibles 2.49M2.19M2.11M88.50M484.73M
Long-Term Deferred Tax 1.93M
Other Non-Current Assets 3.04M8.68M7.92M6.63M8.82M
Non-Current Assets 32.15M75.63M131.47M215.56M734.33M
Liabilities
Current Liabilities
Accounts Payables 1.07M2.82M4.59M3.95M21.61M
Notes Payables 1.07M0.09M0.10M0.04M
Payables 2.15M2.91M4.68M3.99M21.61M
Accumulated Expenses 10.48M32.33M32.90M46.63M81.87M
Short term Debt 0.04M8.43M
Current Leases 0.47M5.95M6.12M13.79M
Current Deferred Revenue 10.00M10.00M56.73M36.43M61.77M
Total Current Liabilities 23.10M46.66M100.27M93.17M187.47M
Non-Current Liabilities
Capital Leases 2.71M9.34M
Non-Current Debt 11.41M0.63M0.54M1.10M19.02M
Non-Current Deffered Revenue 16.67M6.67M70.26M51.24M118.77M
Preferred Stock Liabilities 448.31M
Non-Current Deferred Tax Liability 11.93M16.92M16.57M
Operating Leases 44.42M49.53M67.25M
Other Non-Current Liabilities 4.73M
Total Non-Current Liabilities 409.08M
Liabilities
Total Liabilities 56.56M67.41M215.48M190.26M413.82M
Shareholder's Equity
Total Debt 11.41M0.63M0.54M1.14M27.45M
Common Equity -206.29M542.94M485.81M463.44M1034.78M
Shareholder's Equity -206.29M542.94M485.81M463.44M1034.78M
Liabilities and Shareholders Equity 298.58M610.35M701.29M653.70M1448.60M
Retained Earnings -213.60M-400.08M-639.56M-967.62M-1431.28M
Treasury Shares 0.48M6.89M15.22M27.30M